Arama

EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

PDF

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 15 results

Ranking

Release Date Sort Sort Article Type

Apoptosis and fibrosis in non-alcoholic fatty liver disease

Ali CANBAY, Sertaç N. KİP, Alişan KAHRAMAN, Robert K. GIESELER, Ali NAYCI, Guido GERKEN

(Turk J Gastroenterol 2005; 16: 1-6)

Abstract Full Text ( PDF) Related Articles

Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management

Metin Başaranoğlu, Necati Örmeci

(Turk J Gastroenterol 2014; 25: 127-132) DOI: 10.5152/tjg.2014.7675

Abstract Full Text ( PDF) Related Articles

The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study

Gülbanu Erkan, Irmak Sayın, Fatma Betül Polat, Ahmet Çorakçı, Gökçe Kaan Ataç, Halil Değertekin

(Turk J Gastroenterol 2014; 25: 63-68) DOI: 10.5152/tjg.2014.6233

Abstract Full Text ( PDF) Related Articles

Apoptosis and fibrosis in non-alcoholic fatty liver disease

Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management

The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study

Increased plasma CgA levels associated with nonalcoholic fatty liver disease

The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters

Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis

Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease

Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience

Inborn errors of metabolism in the differential diagnosis of fatty liver disease

The Changing Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) in Turkey in the Last Decade

Comparison of Obesity-Related Indicators for Nonalcoholic Fatty Liver Disease Diagnosed by Transient Elastography

Correlation Between Coronavirus Disease 2019 Severity and Noninvasive Assessment of Liver Fibrosis in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease

A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose

A Plasma Exosomal Metabolic Profiling of Nonalcoholic Fatty Liver Disease Patients Complicated with Impaired Fasting Glucose

Relationship between Neutrophil-to-Lymphocyte Ratio and Liver Fibrosis in Nonalcoholic Fatty Liver Disease Among Adults in the United States: Data from the National Health and Nutrition Examination Survey 2017-2018